Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila

被引:11
作者
Jung, R
Danziger, LH
Pendland, SL
机构
[1] Univ Illinois, Dept Pharm Practice, Microbiol Res Lab, Chicago, IL 60612 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharm Practice, Denver, CO USA
关键词
D O I
10.1093/jac/dkf017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The intracellular activity of ABT-773 against Legionella pneumophila was compared with azithromycin and ciprofloxacin using HL-60 cells. Against L. pneumophila ATCC 33152 and three clinical isolates the MICs (mg/L) were ABT-773 0.015, ciprofloxacin 0.03 and azithromycin 0.03. At 48 h, the mean percentage inhibition was as follows: 28.5 +/- 5.9% and 32.6 +/- 4.6% at 8 x and 16 x MIC of ABT-773; 38.1 +/- 8.6% and 48.2 +/- 7.0% at 8 x and 16 x MIC of ciprofloxacin; and 26.3 +/- 9.9% and 28.5 +/- 9.9% at 8 x and 16 x MIC of azithromycin. In this study, all three agents were highly active, with ABT-773 demonstrating similar activity to azithromycin against L. pneumophila.
引用
收藏
页码:857 / 861
页数:5
相关论文
共 10 条
[1]  
DUBOIS J, 2001, 32 INT C CHEM AMST N
[2]   In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia [J].
Edelstein, PH ;
Higa, F ;
Edelstein, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2685-2690
[3]  
Edelstein PH, 1995, CLIN INFECT DIS S3, V21, P265
[4]  
GUSTAVSON L, 2001, 22 INT C CHEM AMST N
[5]  
MARRA A, 1990, J IMMUNOL, V144, P2738
[6]   Comparative in vitro activity of ABT-773, a novel antibacterial ketolide [J].
Nilius, AM ;
Bui, MH ;
Almer, L ;
Hensey-Rudloff, D ;
Beyer, J ;
Ma, Z ;
Or, YS ;
Flamm, RK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2163-2168
[7]   LIQUID-MEDIUM FOR GROWTH OF LEGIONELLA-PNEUMOPHILA [J].
RISTROPH, JD ;
HEDLUND, KW ;
ALLEN, RG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (01) :19-21
[8]   Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells [J].
Stout, JE ;
Arnold, B ;
Yu, VL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (01) :37-43
[9]   Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells [J].
Stout, JE ;
Arnold, B ;
Yu, VL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (02) :289-291
[10]  
UNERTL KE, 1989, AM J MED S5A, V87, P128